期刊文献+

溶剂环境对乙肝表面抗原(HBsAg)结构的影响 被引量:2

Effects of solvent environment on the structure of hepatitis B surface antigen(HBsAg)
原文传递
导出
摘要 HBsAg作为乙肝疫苗的主要成分,是一种病毒样颗粒,由蛋白质和脂类通过非共价键作用形成。HBsAg保持完整结构对其功能非常重要,而目前未见对其在溶液中结构变化的研究。考察了不同溶剂环境(温度、pH值、离子类型和盐浓度)对HBsAg结构的影响。实验发现,HBsAg在常温下比较稳定,但在温度超过60℃时稳定性明显下降;pH值小于4.0时引起不可逆聚集,但在pH5.0时的聚集部分可逆;不同离子对HBsAg的影响基本符合Hofmeister序列,不同之处是SO42-比F-更易引起HBsAg颗粒的聚集,在所考察的盐中,(NH4)2SO4对HBsAg有着较大的影响,0.4mol/L时就会引起HBsAg聚集,随着浓度增加,聚集现象更加严重,所以在HBsAg的疏水层析中要谨慎使用(NH4)2SO4。 As a virus-like particle,hepatitis B surface antigen(HBsAg) was the primary component of hepatitis B vaccine.HBsAg was maintained by the non-covalent interaction of proteins and lipids.The intact structure of HBsAg particle was vital to its function.However,there was no report about the effects of solvent environment on HBsAg structure.In this paper,we studied the effects of temperature,pH,ionic type and salt concentration on HBsAg structure.The results showed that HBsAg was stable at normal temperature,but began to denature above 60oC.The aggregation of HBsAg at pH 3.0 and 4.0 was nearly irreversible,but partly reversible at pH 5.0.The influence of ionic type on HBsAg was generally in accordance with Hofmeister sequence,except that SO42-caused more aggregation than F-.HBsAg aggregates started to be visible in 0.4 mol/L(NH4)2SO4,and the extent of aggregation increased with the salt concentration.Therefore,caution must be taken when using(NH4)2SO4 in the hydrophobic chromatography purification of HBsAg.
出处 《生物工程学报》 CAS CSCD 北大核心 2010年第12期1674-1682,共9页 Chinese Journal of Biotechnology
基金 国家自然科学基金(Nos.20906093 20820102036) 国家重点基础研究发展计划(973计划)(Nos.2007CB714305 2009CB724705)资助~~
关键词 HBSAG 结构变化 溶剂环境 凝胶过滤高效液相色谱 HBsAg structural change solvent environment gel filtration-high performance liquid chromatography
  • 相关文献

参考文献25

  • 1Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. IntJPharm, 1999, 185(2): 129 188.
  • 2Vermeer AWP, Norde W. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys J, 2000, 78(1): 394-404.
  • 3Zhang J, Peng XD, Jonas A, et al. NMR study of the cold, heat, and pressure unfolding of ribonuclease A. Biochemistry, 1995, 34(27): 8631 8641.
  • 4Chi EY, Krishnan S, Randolph TW, et al. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res, 2003, 20(9): 1325-1336.
  • 5Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm, 2005, 289(1/2): 1-30.
  • 6Son K, Kwon C. Stabilization of human epidermal growth factor (hEGF) in aqueous formulation. Pharm Res, 1995, 12(3): 451-454.
  • 7Chen BL, Arakawa T, Hsu E, et al. Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development. J Pharm Sci, 1994, 83(12): 1657-1661.
  • 8Kohn WD, Kay CM, Hodges RS. Salt effects on protein stability: two-stranded a-helical coiled-coils containing inter- or intrahelical ion pairs. J Mol Biol, 1997, 267(4): 1039-1052.
  • 9李明,Jan-Christer Janson,苏志国.蛋白质在层析过程中的失活与复性[J].化工学报,2004,55(7):1033-1040. 被引量:5
  • 10Spencer DS, Xu K, Logan TM, et al. Effects of pH, salt, and macromolecular crowding on the stability of FK506-binding protein: an integrated experimental and theoretical study. JMolBiol, 2005, 351(1): 219-232.

二级参考文献2

共引文献4

同被引文献21

  • 1张焱,闭静秀,周卫斌,李岩,董爱华,孙娟,苏志国.PEG沉淀结合层析分离重组乙肝病毒表面抗原[J].过程工程学报,2006,6(1):100-103. 被引量:5
  • 2Elghanam M S, Attia A S, Shoeb HA, et al. Expression and purification of hepatitis B surface antigen S from Escherichia coli; a new simple method[J]. BMC Research Notes, 2012, 5:125-133.
  • 3Gurramkonda C, Adnan A, Gabel T, et al. Simple high-cell density fed -batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen[J]. Microb Cell Fact, 2009: 8-13.
  • 4Jung J, Iijima M, Yoshimoto N, et al. Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles from Saccharomyces cerevisiae [J]. Protein Expr Purif, 2011, 78(2): 149-155.
  • 5Nirmala B. Expression in and purification of Hepatitis B surface antig- en(S-protein)from methylotrophie yeast Pichia pastoris [J]. Anaerobe, 2006, 12(4): 194-203.
  • 6闭静秀,周卫斌,苏志国,等.一种分离纯化汉逊酵母表达的重组乙肝表面抗原的方法[P].中国,200610011217.8.2007.07.25.
  • 7Huang Y, Bi J, Zhang Y, et al. A highly efficient integrated chromatog- raphic procedure for the purification of recombinant hepatitis B surfa- ce antigen from Hansenula polymorpha [J]. Protein Expr Purif, 2007,56(2): 301-310.
  • 8李贵兴,张平,张海春,等.一种含铝佐剂乙肝疫苗的制备方法[P].中国,201110126060.4,2011.09.28.
  • 9Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4[J]. Nature, 1970, 227(5259): 680-685.
  • 10European Pharmacopoeia Commission. European Pharmacopoeia(the third edition, 2010) [S]. Hepatitis B vaccine (rDNA), 2010:784-785.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部